BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/28/2016 3:05:00 PM | Browse: 1145 | Download: 1397
Publication Name World Journal of Gastroenterology
Manuscript ID 23989
Country/Territory United Kingdom
Received
2015-12-29 09:07
Peer-Review Started
2015-12-30 14:50
To Make the First Decision
2016-01-28 15:06
Return for Revision
2016-01-29 19:04
Revised
2016-02-09 16:58
Second Decision
2016-02-23 09:32
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2016-03-02 10:38
Articles in Press
2016-03-02 10:38
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2016-03-16 11:22
Publish the Manuscript Online
2016-03-28 15:05
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Meta-Analysis
Article Title Does aspirin or non-aspirin non-steroidal anti-inflammatory drug use prevent colorectal cancer in inflammatory bowel disease?
Manuscript Source Invited Manuscript
All Author List Nick E Burr, Mark A Hull and Venkataraman Subramanian
Funding Agency and Grant Number
Corresponding Author Dr. Venkataraman Subramanian, MD, DM, MRCP, Leeds Institute for Biomedical and Clinical Sciences, St James’s University Hospital, University of Leeds, LS9 7TF Leeds, United Kingdom. nick.burr@nhs.net
Key Words Inflammatory bowel disease; Aspirin; Non-steroidal anti-inflammatory; Colorectal cancer; Chemoprevention
Core Tip Colorectal cancer (CRC) remains a serious complication of inflammatory bowel disease (IBD) and chemoprevention is an attractive alternative to prophylactic surgery or intensive surveillance programs. Aspirin and non-steroidal anti-inflammatory drugs have chemopreventative activity against “sporadic” CRC. We have synthesized the available data for the prevention of IBD associated CRC and found no potential protective effect for either medication. There is a lack of available data on the potential effects of these medications in preventing CRC in patients with IBD and there is a need for high quality, focused studies on this topic.
Publish Date 2016-03-28 15:05
Citation Burr NE, Hull MA, Subramanian V. Does aspirin or non-aspirin non-steroidal anti-inflammatory drug use prevent colorectal cancer in inflammatory bowel disease? World J Gastroenterol 2016; 22(13): 3679-3686
URL http://www.wjgnet.com/1007-9327/full/v22/i13/3679.htm
DOI http://dx.doi.org/10.3748/wjg.v22.i13.3679
Full Article (PDF) WJG-22-3679.pdf
Full Article (Word) WJG-22-3679.doc
Manuscript File 23989-Review.docx
Answering Reviewers 23989-Answering reviewers.pdf
Audio Core Tip 23989-Audio core tip.aac
Biostatistics Review Certificate 23989-Biostatistics statement.pdf
Copyright License Agreement 23989-Copyright assignment.pdf
Peer-review Report 23989-Peer-review(s).pdf
Scientific Misconduct Check 23989-Scientific misconduct check.pdf
Scientific Editor Work List 23989-Scientific editor work list.pdf